Founder & CSO, InnFocus
Dr. Pinchuk has 130 U.S. patents, 100 publications and founded 10 companies. His major accomplishments include the invention of the Nylon 12 angioplasty balloon, the helical wire stent, the modular stent-graft, a drug-eluting stent (TAXUS®, Boston Scientific, Natick, MA), several biomaterials (Bionate® and SIBS), a novel glaucoma tube (the InnFocus MicroShunt®) and the next generation intraocular lens. His inventions are used in more than a hundred million patients with a financial impact well over $100 billion. He was inducted into the National Academy of Engineering in 2012, was awarded the 2017 Society for Biomaterials Innovation and Technology Award, San Antonio’s BIOMED SA Award (2017) and the Ohio University/NAE 2019 Fritz J. and Dolores H. Russ Prize – which some consider the world’s top prize in engineering.
He received a B.Sc. in chemistry from McGill University (Montreal, Canada, 1976) and a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami (Miami, Florida, 1984). Dr. Pinchuk co-founded Corvita Corporation (1987) which went public in 1994, was acquired by Pfizer, Inc. (1996) and then sold to Boston Scientific (1998). He then founded Innovia LLC (2002), which spun-out InnFocus, Inc. (2004) which was acquired by Santen Pharmaceuticals in 2016 and Innolene LLC, (2010) developing intraocular lenses. Dr. Pinchuk also enjoys an appointment as Distinguished Research Professor of Biomedical Engineering at the University of Miami.